Polychronis Cancer Services Limited - Accounts to registrar (filleted)

REGISTERED NUMBER: 07418642 (England and Wales)

POLYCHRONIS CANCER SERVICES LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 OCTOBER 2025

Page

Company Information

1

Statement of Financial Position

2

Notes to the Financial Statements

4

DIRECTOR:

Dr A Polychronis

REGISTERED OFFICE:

143 Hadley Road

Barnet

EN5 5QN

REGISTERED NUMBER:

07418642 (England and Wales)

ACCOUNTANTS:

TCA (Shrewsbury) LLP

Third Floor

21 St Mary's Street

Shrewsbury

Shropshire

SY1 1ED

FIXED ASSETS

Intangible assets

4

-

Tangible assets

5

10,416

14,171

Investments

6

310,003

89,777

Investment property

7

584,720

905,139

688,668

CURRENT ASSETS

Debtors

8

38,830

43,788

Cash at bank

1,393,667

1,340,608

1,432,497

1,384,396

CREDITORS

Amounts falling due within one year

9

441,278

456,976

NET CURRENT ASSETS

991,219

927,420

TOTAL ASSETS LESS CURRENT
LIABILITIES

1,896,358

1,616,088

PROVISIONS FOR LIABILITIES

2,604

3,543

NET ASSETS

1,893,754

1,612,545

CAPITAL AND RESERVES

Called up share capital

11

2

Capital redemption reserve

1

Retained earnings

1,893,751

1,612,542

SHAREHOLDERS' FUNDS

1,893,754

1,612,545

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 8 July 2026 and were signed by:

Dr A Polychronis - Director

1.	STATUTORY INFORMATION

Polychronis Cancer Services Limited is a private company, limited by shares, registered in England and Wales. The company's registered number is 07418642 and registered office address is:

143 Hadley Road

Barnet

England

EN5 5QN

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of the business from the director upon incorporation was £60,000 and has been fully amortised.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.

Fixtures and fittings

- 25% on cost

Motor vehicles

- 33% on reducing balance

Equipment

- 25% on cost

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and will be recognised in the profit and loss account.

Investment property

Investment property, which is property held to earn rentals and/or capital appreciation, is initially recognised at cost, which includes the purchase cost and any directly attributable expenditure.

Subsequently it is measured at fair value at the reporting end date. This is determined annually by reviewing current market rents and investment property yields for comparable real estate, adjusted if necessary for any differences in the nature, location or condition of the specific asset. No depreciation is provided. The surplus or deficit on the revaluation is recognised in the profit and loss account.

Valuation of investments

Investments in a managed portfolio are measured at cost less accumulated impairment.The surplus or deficit on the revaluation is recognised in the profit and loss account. Fair value is estimated by using quoted prices provided by the fund manager.

Financial instruments

The Company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares. Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the profit and loss account.

For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Debtors

Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Creditors

Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Interest income

Interest income is recognised in the Profit and loss account using the effective interest method.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2024 - 1 ) .

4.	INTANGIBLE FIXED ASSETS

Goodwill

£

COST

At 1 November 2024

and 31 October 2025

60,000

AMORTISATION

At 1 November 2024

and 31 October 2025

60,000

NET BOOK VALUE

At 31 October 2025

-

At 31 October 2024

-

5.	TANGIBLE FIXED ASSETS

Fixtures

and

Motor

fittings

vehicles

Equipment

Totals

£

COST

At 1 November 2024

6,544

75,725

15,713

97,982

Additions

1,613

-

1,399

3,012

Disposals

-

(1,399

)

(1,399

)

At 31 October 2025

8,157

75,725

15,713

99,595

DEPRECIATION

At 1 November 2024

5,762

65,723

12,326

83,811

Charge for year

794

3,334

1,590

5,718

Eliminated on disposal

-

(350

)

(350

)

At 31 October 2025

6,556

69,057

13,566

89,179

NET BOOK VALUE

At 31 October 2025

1,601

6,668

2,147

10,416

At 31 October 2024

782

10,002

3,387

14,171

6.	FIXED ASSET INVESTMENTS

Unlisted

investments

£

COST OR VALUATION

At 1 November 2024

89,777

Additions

194,300

Revaluations

25,926

At 31 October 2025

310,003

NET BOOK VALUE

At 31 October 2025

310,003

At 31 October 2024

89,777

Cost or valuation at 31 October 2025 is represented by:

Unlisted

investments

£

Valuation in 2019

68,780

Valuation in 2020

(2,956

)

Valuation in 2022

8,450

Valuation in 2023

5,485

Valuation in 2024

10,018

Valuation in 2025

220,226

310,003

7.	INVESTMENT PROPERTY

Total

£

FAIR VALUE

At 1 November 2024

and 31 October 2025

584,720

NET BOOK VALUE

At 31 October 2025

584,720

At 31 October 2024

584,720

8.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

Trade debtors

38,830

43,788

9.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

Trade creditors

4,284

4,104

Tax

138,008

147,934

Other creditors

251,914

Directors' loan accounts

7,072

53,024

Accrued expenses

40,000

-

441,278

456,976

10.	LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:

2025

2024

£

Within one year

9,475

Between one and five years

18,160

27,634

27,635

37,109

11.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2025

2024

value:

£

1

Ordinary A shares

1

Ordinary B shares

1

-

1

Ordinary C shares

1

2